Close

Patient Adherence

HIMSS15 – HIMSSANITY a Meta View from the Floors

Posted on April 17, 2015 by Amos Adler

What a crazy few days its been at HIMSS. While I can describe all the sessions and attendees I’ll spare you what you can read on their website and focus on the experiential part of the event. Think 43,000 people crammed into the cozy corner of Chicago at McKormick Place, the world’s second largest exhibition hall. What’s interesting about HIMMSS is its massive scale, overwhelming number of people, exhibitions and the sheer size of the booze, cappuccino, swag filled conference. One of the best parts is the exercise of walking 8 miles a day all around the event hall. I wanted to understand the commercial focus of the event from a competitive perspective as well as to get inspired and understand the marketplace.

Read More

Are You Doing Your Due Diligence? – Brought to you by MEMOTEXT‏

16 Steps to m/Digital Health Success

Posted on April 2, 2015 by Amos Adler

As mobile and digital health get more and more traction, you might be evaluating various m/digital health technologies and solutions. From new-starts to established legacy service providers there are a lot of options to choose from. It pays to have some digital health due-diligence planning in place. Fortunately, we at MEMOTEXT have learned some digital health lessons in due-diligence and hope to speed up the process for you. Don’t worry, we validated this methodology ourselves the hard way!

Read More

MEMOTEXT Goes to Boston for Unpack! 2015

Posted on March 30, 2015 by Amos Adler

On March. 17 – 18 2015, MEMOTEXT had the honor to attend the Unpack! 2015. Represented by our Founder and President Amos Adler, MEMOTEXT was one of 15 Canadian digital/mobile health companies invited to attend. Unpack! 2015 was organized by the Canadian Entrepreneurs in New England (CENE), and facilitated by the Consulate General of Canada in Boston. The goal of the two day event was to connect Canadian Telehealth & Healthcare Robotics Companies with their Boston based American counterparts.

Read More

MEMOTEXT Does it’s Part to Help Fight Glaucoma

Posted on March 11, 2015 by Noah Nemoy

This March 8-15, is World Glaucoma Week. Launched 6 years ago by the World Glaucoma Association and The World Glaucoma Patient Association, events are being held across the world to raise awareness about Glaucoma. Afflicting 9 million people, Glaucoma is the world’s leading cause of irreversible blindness. Due to its slow progression, 50% of patients in the developed world and 90% in the developing world are untreated. While Glaucoma is currently incurable, with early detection and treatment, its progression can be halted.

Read More

Are you ready for this?… Behavior change…For your organization.

Posted on March 05, 2015 by Amos Adler

Some of our MEMOTEXT programs personalize interventions based on what’s known as stages of change. Stage of change, or the transtheoretical model, is used to asses and prescribe appropriate information, motivation and guidance to move people towards behavior change. In plain English, are people ready to adopt healthier behaviors?

Read More

MEMOTEXT in 2014 part of the growth of mHealth Companies

Posted on February 6, 2015 by Noah Nemoy

The past year has been one of tremendous growth and new opportunities for both MEMOTEXT – one of the pioneering mHealth companies – and mHealth as a whole. The two trends that power the mHealth revolution; increased usage of mobile technology and the move towards decentralized and personalized health care, have continued unabated. While mHealth is an industry still largely in its infancy, the use of this technology will only increase as the gap between the 10% of smartphone owners using health apps and 72% of patients using mobile apps, continues to close.

Read More

They’re Not Just “Feelings”: Why We Should Pay Attention to the Way People Feel About Their Medications

Posted on February 2, 2015 by Bill Simpson

I am not a medical historian, but I would bet that if you asked one, they would identify the synthesis of Aspirin in 1897 as one of most significant moments in modern medicine. With its pain-relieving, anti-inflammatory and anti-platelet (blood thinning) properties packaged within a single tablet, Aspirin provided a safe, effective and easy treatment for a wide range of illnesses. Even today, it is listed on the World Health Organization’s List of Essential Medicines and is taken daily by millions of people for the prevention of heart attacks and strokes. Its synthesis (and the pharmaceutical revolution it helped to user in) has no doubt helped to increase our lifespan and bring about a higher quality of life.

Read More

Do Patients Want to Get Better?

Posted on December 6, 2013 by Elisha Zavier

Medication compliance is a hot topic within the healthcare space. The problem is not just that patients are not taking their medication, they are also not following the lifestyle required to improve their health outcomes. There are direct and indirect ramifications of patient non-compliance that seep into various facets of everyday life – including the ability of patients, especially those affected by chronic diseases, to perform at their jobs.

Read More

MEMOTEXT featured at eHealth Innovation Summit in Philadelphia Nov 19

International Collaboration Puts the Future of Healthcare IT on Display at the University City Science Center

The fifth annual eHealth Innovation Summit on Nov. 19 highlights Canada’s influential entrepreneurs as they look to land a permanent home in the U.S.

Philadelphia, PA (PRWEB) November 15, 2013 – Eleven emerging Canadian healthcare IT companies will participate in a demonstration day on Nov. 19 from 9 a.m. – 3 p.m. at the University City Science Center. The program will take place at Quorum at 3711 Market St., 8th Floor in Philadelphia.

Read More